 <h1>Mycapssa Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>octreotide</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about octreotide. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Mycapssa.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to octreotide: powder for suspension, solution</i></p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, octreotide (the active ingredient contained in Mycapssa) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<b>Check with your doctor immediately</b> if any of the following side effects occur while taking octreotide:</p><p>
<i>More common</i>
</p><ul>
<li>Constipation</li>
<li>depressed mood</li>
<li>diarrhea</li>
<li>dizziness</li>
<li>dry skin and hair</li>
<li>fainting</li>
<li>fast, slow, or irregular heartbeat</li>
<li>feeling cold</li>
<li>hair loss</li>
<li>hoarseness or husky voice</li>
<li>loss of appetite</li>
<li>muscle cramps and stiffness</li>
<li>nausea</li>
<li>severe stomach pain with nausea and vomiting</li>
<li>stomach pain</li>
<li>unusual tiredness or weakness</li>
<li>vomiting</li>
<li>weight gain</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Anxiety</li>
<li>bladder pain</li>
<li>bloody or cloudy urine</li>
<li>blurred vision</li>
<li>chills</li>
<li>cold sweats</li>
<li>collection of blood under the skin</li>
<li>confusion</li>
<li>cool, pale skin</li>
<li>deep, dark purple bruise</li>
<li>difficult, burning, or painful urination</li>
<li>dry mouth</li>
<li>flushed, dry skin</li>
<li>frequent urge to urinate</li>
<li>fruit-like breath odor</li>
<li>headache</li>
<li>increased hunger</li>
<li>increased thirst</li>
<li>increased urination</li>
<li>itching, pain, redness, or swelling</li>
<li>loss of consciousness</li>
<li>lower back or side pain</li>
<li>nervousness</li>
<li>nightmares</li>
<li>seizures</li>
<li>shakiness</li>
<li>slurred speech</li>
<li>sweating</li>
<li>swelling</li>
<li>troubled breathing</li>
<li>unexplained weight loss</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Black, tarry stools</li>
<li>bleeding gums</li>
<li>blood in vomit</li>
<li>changes in skin color, pain, tenderness, swelling of the foot or leg</li>
<li>chest pain</li>
<li>cough</li>
<li>coughing up blood</li>
<li>dark urine</li>
<li>decreased urine output</li>
<li>difficulty in breathing or swallowing</li>
<li>difficulty swallowing</li>
<li>dilated neck veins</li>
<li>extreme tiredness or weakness</li>
<li>fast, irregular, pounding, or racing heartbeat or pulse</li>
<li>fever</li>
<li>hives, itching, skin rash</li>
<li>increased menstrual flow or vaginal bleeding</li>
<li>irregular breathing</li>
<li>itching, pain, redness, swelling, tenderness, or warmth on the skin</li>
<li>light-colored stools</li>
<li>nosebleeds</li>
<li>pain in the groin or genitals</li>
<li>pale skin</li>
<li>paleness or cold feeling in the fingertips and toes</li>
<li>paralysis</li>
<li>pounding in the ears</li>
<li>prolonged bleeding from cuts</li>
<li>puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue</li>
<li>red or dark brown urine</li>
<li>severe or continuing stomach pain</li>
<li>sharp back pain just below the ribs</li>
<li>sneezing</li>
<li>sore throat</li>
<li>swelling of the face, fingers, feet, or lower legs</li>
<li>tightness in the chest</li>
<li>tingling or pain in the fingers or toes when exposed to cold temperatures</li>
<li>tremor</li>
<li>troubled breathing with exertion</li>
<li>unusual bleeding or bruising</li>
<li>upper right abdominal pain</li>
<li>yellow eyes and skin</li>
</ul><p>
<i>Incidence not known</i>
</p><ul>
<li>Bloating</li>
<li>gaseous</li>
<li>indigestion</li>
<li>pains in the stomach, side, or abdomen, possibly radiating to the back</li>
<li>pinpoint red spots on the skin</li>
<li>recurrent fever</li>
<li>severe constipation</li>
<li>stomach fullness</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of octreotide may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Abnormal stool</li>
<li>excess air or gas in the stomach or bowels</li>
<li>full feeling</li>
<li>pain, redness, stinging, swelling, tingling, or burning sensation at the injection site</li>
<li>passing of gas</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Backache</li>
<li>feeling of warmth</li>
<li>hair loss</li>
<li>joint pain</li>
<li>redness of the face, neck, arms and occasionally, upper chest</li>
</ul><p>
<i>Rare</i>
</p><ul>
<li>Absent, missed, or irregular menstrual periods</li>
<li>change in vision</li>
<li>difficulty in moving</li>
<li>feeling of constant movement of self or surroundings</li>
<li>hearing loss</li>
<li>itching of the vagina or genital area</li>
<li>joint swelling or redness</li>
<li>loss of vision</li>
<li>memory loss</li>
<li>muscle pain</li>
<li>numbness or tingling of the hands, feet, or face</li>
<li>pain during sexual intercourse</li>
<li>sensation of spinning</li>
<li>stopping of menstrual bleeding</li>
<li>swelling of the breasts or breast soreness in both females and males</li>
<li>thick, white vaginal discharge with no odor or with a mild odor</li>
<li>unexpected or excess milk flow from the breasts</li>
</ul><p>
<!-- end powder for suspension, solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to octreotide: injectable solution, intramuscular powder for injection extended release, oral delayed release capsule, subcutaneous solution</i></p><h3>General</h3><p>The most common adverse events were gastrointestinal disorders, nervous system disorders, hepatobiliary disorders, and metabolism and nutritional disorders.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (57.9%), abdominal pain (43.9%), nausea (29.8%), flatulence (25.3%), constipation (18.8%), abdominal pain upper (10.5%), abdominal discomfort, loose stools </p>
<p><b>Common</b> (1% to 10%): Fat malabsorption, vomiting, dyspepsia, steatorrhea, discoloration of feces, tenesmus, abdominal distension</p>
<p><b>Uncommon</b> (0.1% to 1%): GI bleeding, hemorrhoids, appendicitis, gastric/peptic ulcer</p>
<p><b>Frequency not reported</b>: Pancreatitis, vomiting, abnormal stools, severe epigastric pain, abdominal tenderness and guarding</p>
<p><b>Postmarketing reports</b>: Intestinal obstruction<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Bradycardia (25%), hypertension (12.6%), conduction abnormalities (10%)</p>
<p><b>Common</b> (1% to 10%): Arrhythmias, flushing</p>
<p><b>Uncommon</b> (0.1% to 1%): Chest pain, shortness of breath, thrombophlebitis, ischemia, congestive heart failure, palpitations, orthostatic blood pressure decrease, tachycardia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Gallstones (27%), sludge without stones (24%), cholelithiasis (38.2%), biliary duct dilatation (12%)</p>
<p><b>Common</b> (1% to 10%): Transaminase increased</p>
<p><b>Uncommon</b> (0.1% to 1%): Hepatitis, jaundice, increase in liver enzymes, gallbladder polyp</p>
<p><b>Rare</b> (less than 0.1%): Acute pancreatitis</p>
<p><b>Frequency not reported</b>: Acute cholecystitis, ascending cholangitis, biliary obstruction, cholestatic hepatitis, pancreatitis<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (30%), dizziness (20%)</p>
<p><b>Uncommon</b> (0.1% to 1%): Syncope, tremor, seizure, vertigo, Bell's palsy, pituitary apoplexy, amnesia, neuritis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Hyperglycemia (16%)</p>
<p><b>Common</b> (1% to 10%): Hypoglycemia, edema, anorexia</p>
<p><b>Uncommon</b> (0.1% to 1%): Weight loss, dehydration</p>
<p><b>Frequency not reported</b>: Depressed vitamin B12 levels, abnormal Schilling's test<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Anemia (15.3%)</p>
<p><b>Uncommon</b> (0.1% to 1%): Iron deficiency</p>
<p><b>Postmarketing reports</b>: Thrombocytopenia<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Very common</b> (10% or more): Biochemical hypothyroidism (12%) </p>
<p><b>Common</b> (1% to 10%): Goiter, thyroid dysfunction (e.g.  decreased TSH, decreased Total T4, and decreased Free T4)</p>
<p><b>Uncommon</b> (0.1% to 1%): Galactorrhea, hypoadrenalism, diabetes insipidus<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Injection site pain (13.8%), injection site reactions</p>
<p><b>Common</b> (1% to 10%): Injection site hematoma<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Alopecia (13.2%)</p>
<p><b>Common</b> (1% to 10%): Pruritus, bruise, rash</p>
<p><b>Uncommon</b> (0.1% to 1%): Cellulitis, petechiae, urticaria, basal cell carcinoma<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Joint pain, backache</p>
<p><b>Uncommon</b> (0.1% to 1%): Arthritis, joint effusion, muscle pain, Raynaud's phenomenon<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Depression</p>
<p><b>Uncommon</b> (0.1% to 1%): Anxiety, paranoia, libido decrease<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (31.8%), generalized pain (15%) </p>
<p><b>Common</b> (1% to 10%): Weakness </p>
<p><b>Uncommon</b> (0.1% to 1%): Hearing loss, otitis<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Upper respiratory tract infection (18.2%), sinusitis (12%)</p>
<p><b>Common</b> (1% to 10%): Cold symptoms, flu symptoms, epistaxis </p>
<p><b>Uncommon</b> (0.1% to 1%): Pneumonia, pulmonary nodule, status asthmaticus<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Uncommon</b> (0.1% to 1%): Increased creatinine kinase<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Allergic reaction</p>
<p><b>Frequency not reported</b>: Anaphylactic reaction<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Antibodies to octreotide (the active ingredient contained in Mycapssa) (25%)</p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Blurred vision, visual disturbance</p>
<p><b>Uncommon</b> (0.1% to 1%): Increased intraocular pressure<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection, pollakiuria</p>
<p><b>Uncommon</b> (0.1% to 1%): Gynecomastia, amenorrhea, polymenorrhea, oligomenorrhea, vaginitis, nephrolithiasis, hematuria<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Octreotide Acetate (octreotide)." Teva SICOR Pharmaceuticals Inc, Irvine, CA. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_4">4. "Product Information. Sandostatin (octreotide)." Sandoz Pharmaceuticals Corporation, East Hanover, NJ. </p><p id="ref_5">5. "Product Information. SandoSTATIN LAR Depot (octreotide)." Novartis Consumer Health, Parsippany, NJ. </p></div>
<div class="more-resources" id="moreResources">
<h2>More about Mycapssa (octreotide)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: somatostatin and somatostatin analogs</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Mycapssa &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<dl class="more-resources-other-brands more-resources-other-brands-consumer"><dt>Other brands</dt><dd>Sandostatin, Sandostatin LAR Depot, Bynfezia Pen</dd></dl>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Acromegaly</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to octreotide: injectable solution, intramuscular powder for injection extended release, oral delayed release capsule, subcutaneous solution</i></p><h3>General</h3><p>The most common adverse events were gastrointestinal disorders, nervous system disorders, hepatobiliary disorders, and metabolism and nutritional disorders.<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p><b>Very common</b> (10% or more): Diarrhea (57.9%), abdominal pain (43.9%), nausea (29.8%), flatulence (25.3%), constipation (18.8%), abdominal pain upper (10.5%), abdominal discomfort, loose stools </p><p><b>Common</b> (1% to 10%): Fat malabsorption, vomiting, dyspepsia, steatorrhea, discoloration of feces, tenesmus, abdominal distension</p><p><b>Uncommon</b> (0.1% to 1%): GI bleeding, hemorrhoids, appendicitis, gastric/peptic ulcer</p><p><b>Frequency not reported</b>: Pancreatitis, vomiting, abnormal stools, severe epigastric pain, abdominal tenderness and guarding</p><p><b>Postmarketing reports</b>: Intestinal obstruction<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p><b>Very common</b> (10% or more): Bradycardia (25%), hypertension (12.6%), conduction abnormalities (10%)</p><p><b>Common</b> (1% to 10%): Arrhythmias, flushing</p><p><b>Uncommon</b> (0.1% to 1%): Chest pain, shortness of breath, thrombophlebitis, ischemia, congestive heart failure, palpitations, orthostatic blood pressure decrease, tachycardia<sup>[Ref]</sup></p><h3>Hepatic</h3><p><b>Very common</b> (10% or more): Gallstones (27%), sludge without stones (24%), cholelithiasis (38.2%), biliary duct dilatation (12%)</p><p><b>Common</b> (1% to 10%): Transaminase increased</p><p><b>Uncommon</b> (0.1% to 1%): Hepatitis, jaundice, increase in liver enzymes, gallbladder polyp</p><p><b>Rare</b> (less than 0.1%): Acute pancreatitis</p><p><b>Frequency not reported</b>: Acute cholecystitis, ascending cholangitis, biliary obstruction, cholestatic hepatitis, pancreatitis<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Headache (30%), dizziness (20%)</p><p><b>Uncommon</b> (0.1% to 1%): Syncope, tremor, seizure, vertigo, Bell's palsy, pituitary apoplexy, amnesia, neuritis<sup>[Ref]</sup></p><h3>Metabolic</h3><p><b>Very common</b> (10% or more): Hyperglycemia (16%)</p><p><b>Common</b> (1% to 10%): Hypoglycemia, edema, anorexia</p><p><b>Uncommon</b> (0.1% to 1%): Weight loss, dehydration</p><p><b>Frequency not reported</b>: Depressed vitamin B12 levels, abnormal Schilling's test<sup>[Ref]</sup></p><h3>Hematologic</h3><p><b>Very common</b> (10% or more): Anemia (15.3%)</p><p><b>Uncommon</b> (0.1% to 1%): Iron deficiency</p><p><b>Postmarketing reports</b>: Thrombocytopenia<sup>[Ref]</sup></p><h3>Endocrine</h3><p><b>Very common</b> (10% or more): Biochemical hypothyroidism (12%) </p><p><b>Common</b> (1% to 10%): Goiter, thyroid dysfunction (e.g.  decreased TSH, decreased Total T4, and decreased Free T4)</p><p><b>Uncommon</b> (0.1% to 1%): Galactorrhea, hypoadrenalism, diabetes insipidus<sup>[Ref]</sup></p><h3>Local</h3><p><b>Very common</b> (10% or more): Injection site pain (13.8%), injection site reactions</p><p><b>Common</b> (1% to 10%): Injection site hematoma<sup>[Ref]</sup></p><h3>Dermatologic</h3><p><b>Very common</b> (10% or more): Alopecia (13.2%)</p><p><b>Common</b> (1% to 10%): Pruritus, bruise, rash</p><p><b>Uncommon</b> (0.1% to 1%): Cellulitis, petechiae, urticaria, basal cell carcinoma<sup>[Ref]</sup></p><h3>Musculoskeletal</h3><p><b>Common</b> (1% to 10%): Joint pain, backache</p><p><b>Uncommon</b> (0.1% to 1%): Arthritis, joint effusion, muscle pain, Raynaud's phenomenon<sup>[Ref]</sup></p><h3>Psychiatric</h3><p><b>Common</b> (1% to 10%): Depression</p><p><b>Uncommon</b> (0.1% to 1%): Anxiety, paranoia, libido decrease<sup>[Ref]</sup></p><h3>Other</h3><p><b>Very common</b> (10% or more): Fatigue (31.8%), generalized pain (15%) </p><p><b>Common</b> (1% to 10%): Weakness </p><p><b>Uncommon</b> (0.1% to 1%): Hearing loss, otitis<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Very common</b> (10% or more): Upper respiratory tract infection (18.2%), sinusitis (12%)</p><p><b>Common</b> (1% to 10%): Cold symptoms, flu symptoms, epistaxis </p><p><b>Uncommon</b> (0.1% to 1%): Pneumonia, pulmonary nodule, status asthmaticus<sup>[Ref]</sup></p><h3>Renal</h3><p><b>Uncommon</b> (0.1% to 1%): Increased creatinine kinase<sup>[Ref]</sup></p><h3>Hypersensitivity</h3><p><b>Uncommon</b> (0.1% to 1%): Allergic reaction</p><p><b>Frequency not reported</b>: Anaphylactic reaction<sup>[Ref]</sup></p><h3>Immunologic</h3><p><b>Very common</b> (10% or more): Antibodies to octreotide (the active ingredient contained in Mycapssa) (25%)</p><h3>Ocular</h3><p><b>Common</b> (1% to 10%): Blurred vision, visual disturbance</p><p><b>Uncommon</b> (0.1% to 1%): Increased intraocular pressure<sup>[Ref]</sup></p><h3>Genitourinary</h3><p><b>Common</b> (1% to 10%): Urinary tract infection, pollakiuria</p><p><b>Uncommon</b> (0.1% to 1%): Gynecomastia, amenorrhea, polymenorrhea, oligomenorrhea, vaginitis, nephrolithiasis, hematuria<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Octreotide Acetate (octreotide)." Teva SICOR Pharmaceuticals Inc, Irvine, CA. </p><p id="ref_2">2. Cerner Multum,  Inc. "Australian Product Information." O 0</p><p id="ref_3">3. Cerner Multum,  Inc. "UK Summary of Product Characteristics." O 0</p><p id="ref_4">4. "Product Information. Sandostatin (octreotide)." Sandoz Pharmaceuticals Corporation, East Hanover, NJ. </p><p id="ref_5">5. "Product Information. SandoSTATIN LAR Depot (octreotide)." Novartis Consumer Health, Parsippany, NJ. </p><h2>More about Mycapssa (octreotide)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Images</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: somatostatin and somatostatin analogs</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Mycapssa &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Acromegaly</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>